nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP2D6—Hydroxyurea—head and neck cancer	0.282	0.567	CbGbCtD
Cevimeline—CYP2D6—Vinblastine—head and neck cancer	0.0998	0.201	CbGbCtD
Cevimeline—CYP3A4—Vinblastine—head and neck cancer	0.0635	0.128	CbGbCtD
Cevimeline—CYP3A4—Docetaxel—head and neck cancer	0.0523	0.105	CbGbCtD
Cevimeline—Rash erythematous—Docetaxel—head and neck cancer	0.0024	0.00477	CcSEcCtD
Cevimeline—Angina pectoris—Vinblastine—head and neck cancer	0.00237	0.00471	CcSEcCtD
Cevimeline—Otitis media—Docetaxel—head and neck cancer	0.00236	0.00469	CcSEcCtD
Cevimeline—Oesophagitis—Fluorouracil—head and neck cancer	0.00232	0.00462	CcSEcCtD
Cevimeline—Coma—Fluorouracil—head and neck cancer	0.00232	0.00462	CcSEcCtD
Cevimeline—Rigors—Docetaxel—head and neck cancer	0.00225	0.00447	CcSEcCtD
Cevimeline—Sepsis—Fluorouracil—head and neck cancer	0.00221	0.00439	CcSEcCtD
Cevimeline—Depression—Vinblastine—head and neck cancer	0.00216	0.0043	CcSEcCtD
Cevimeline—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00214	0.00425	CcSEcCtD
Cevimeline—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00213	0.00424	CcSEcCtD
Cevimeline—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00212	0.00423	CcSEcCtD
Cevimeline—Myocardial infarction—Vinblastine—head and neck cancer	0.00212	0.00423	CcSEcCtD
Cevimeline—Amenorrhoea—Docetaxel—head and neck cancer	0.00209	0.00416	CcSEcCtD
Cevimeline—Dysuria—Hydroxyurea—head and neck cancer	0.00207	0.00412	CcSEcCtD
Cevimeline—Bone disorder—Docetaxel—head and neck cancer	0.00203	0.00404	CcSEcCtD
Cevimeline—Agranulocytosis—Vinblastine—head and neck cancer	0.00202	0.00402	CcSEcCtD
Cevimeline—Weight increased—Hydroxyurea—head and neck cancer	0.00202	0.00401	CcSEcCtD
Cevimeline—Oliguria—Docetaxel—head and neck cancer	0.00199	0.00396	CcSEcCtD
Cevimeline—Amnesia—Fluorouracil—head and neck cancer	0.00196	0.00391	CcSEcCtD
Cevimeline—Haemoglobin—Vinblastine—head and neck cancer	0.00195	0.00389	CcSEcCtD
Cevimeline—Haemorrhage—Vinblastine—head and neck cancer	0.00194	0.00387	CcSEcCtD
Cevimeline—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00194	0.00385	CcSEcCtD
Cevimeline—Hypoaesthesia—Vinblastine—head and neck cancer	0.00193	0.00385	CcSEcCtD
Cevimeline—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00193	0.00384	CcSEcCtD
Cevimeline—Pharyngitis—Vinblastine—head and neck cancer	0.00193	0.00384	CcSEcCtD
Cevimeline—Hearing impaired—Docetaxel—head and neck cancer	0.00193	0.00384	CcSEcCtD
Cevimeline—Stomatitis—Hydroxyurea—head and neck cancer	0.00193	0.00383	CcSEcCtD
Cevimeline—Bone pain—Docetaxel—head and neck cancer	0.00191	0.00381	CcSEcCtD
Cevimeline—Osteoarthritis—Fluorouracil—head and neck cancer	0.00184	0.00367	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00184	0.00367	CcSEcCtD
Cevimeline—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00183	0.00365	CcSEcCtD
Cevimeline—Pulmonary embolism—Docetaxel—head and neck cancer	0.00183	0.00365	CcSEcCtD
Cevimeline—Haemoglobin—Hydroxyurea—head and neck cancer	0.00178	0.00355	CcSEcCtD
Cevimeline—Influenza like illness—Docetaxel—head and neck cancer	0.00178	0.00355	CcSEcCtD
Cevimeline—Haemorrhage—Hydroxyurea—head and neck cancer	0.00177	0.00353	CcSEcCtD
Cevimeline—Hallucination—Hydroxyurea—head and neck cancer	0.00176	0.00351	CcSEcCtD
Cevimeline—Candida infection—Docetaxel—head and neck cancer	0.00175	0.00349	CcSEcCtD
Cevimeline—Skin exfoliation—Docetaxel—head and neck cancer	0.00175	0.00349	CcSEcCtD
Cevimeline—Neuropathy—Docetaxel—head and neck cancer	0.00172	0.00343	CcSEcCtD
Cevimeline—Alopecia—Vinblastine—head and neck cancer	0.00172	0.00342	CcSEcCtD
Cevimeline—Dry skin—Fluorouracil—head and neck cancer	0.00169	0.00337	CcSEcCtD
Cevimeline—Oesophagitis—Docetaxel—head and neck cancer	0.00168	0.00334	CcSEcCtD
Cevimeline—Neoplasm—Docetaxel—head and neck cancer	0.00166	0.0033	CcSEcCtD
Cevimeline—Muscular weakness—Fluorouracil—head and neck cancer	0.00163	0.00324	CcSEcCtD
Cevimeline—Angiopathy—Hydroxyurea—head and neck cancer	0.00161	0.0032	CcSEcCtD
Cevimeline—Dysphagia—Fluorouracil—head and neck cancer	0.00159	0.00317	CcSEcCtD
Cevimeline—Sepsis—Docetaxel—head and neck cancer	0.00159	0.00317	CcSEcCtD
Cevimeline—Chills—Hydroxyurea—head and neck cancer	0.00159	0.00317	CcSEcCtD
Cevimeline—Eosinophilia—Fluorouracil—head and neck cancer	0.00158	0.00314	CcSEcCtD
Cevimeline—Ill-defined disorder—Vinblastine—head and neck cancer	0.00157	0.00313	CcSEcCtD
Cevimeline—Alopecia—Hydroxyurea—head and neck cancer	0.00157	0.00312	CcSEcCtD
Cevimeline—Anaemia—Vinblastine—head and neck cancer	0.00156	0.00311	CcSEcCtD
Cevimeline—Angina pectoris—Fluorouracil—head and neck cancer	0.00155	0.00309	CcSEcCtD
Cevimeline—Thrombophlebitis—Docetaxel—head and neck cancer	0.00154	0.00306	CcSEcCtD
Cevimeline—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00153	0.00305	CcSEcCtD
Cevimeline—Malaise—Vinblastine—head and neck cancer	0.00153	0.00304	CcSEcCtD
Cevimeline—Vertigo—Vinblastine—head and neck cancer	0.00152	0.00303	CcSEcCtD
Cevimeline—Leukopenia—Vinblastine—head and neck cancer	0.00152	0.00302	CcSEcCtD
Cevimeline—Deafness—Docetaxel—head and neck cancer	0.00149	0.00296	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00148	0.00295	CcSEcCtD
Cevimeline—Convulsion—Vinblastine—head and neck cancer	0.00147	0.00292	CcSEcCtD
Cevimeline—Hypertension—Vinblastine—head and neck cancer	0.00146	0.00291	CcSEcCtD
Cevimeline—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00146	0.0029	CcSEcCtD
Cevimeline—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00143	0.00285	CcSEcCtD
Cevimeline—Pneumonia—Fluorouracil—head and neck cancer	0.00143	0.00285	CcSEcCtD
Cevimeline—Anaemia—Hydroxyurea—head and neck cancer	0.00143	0.00284	CcSEcCtD
Cevimeline—Discomfort—Vinblastine—head and neck cancer	0.00142	0.00283	CcSEcCtD
Cevimeline—Hot flush—Docetaxel—head and neck cancer	0.00142	0.00283	CcSEcCtD
Cevimeline—Menopausal symptoms—Docetaxel—head and neck cancer	0.00141	0.00281	CcSEcCtD
Cevimeline—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.0014	0.00279	CcSEcCtD
Cevimeline—Renal impairment—Docetaxel—head and neck cancer	0.0014	0.00279	CcSEcCtD
Cevimeline—Myocardial infarction—Fluorouracil—head and neck cancer	0.00139	0.00277	CcSEcCtD
Cevimeline—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00139	0.00277	CcSEcCtD
Cevimeline—Dermatitis bullous—Docetaxel—head and neck cancer	0.00139	0.00277	CcSEcCtD
Cevimeline—Malaise—Hydroxyurea—head and neck cancer	0.00139	0.00277	CcSEcCtD
Cevimeline—Stomatitis—Fluorouracil—head and neck cancer	0.00139	0.00276	CcSEcCtD
Cevimeline—Conjunctivitis—Fluorouracil—head and neck cancer	0.00138	0.00275	CcSEcCtD
Cevimeline—Urinary tract infection—Fluorouracil—head and neck cancer	0.00138	0.00275	CcSEcCtD
Cevimeline—Leukopenia—Hydroxyurea—head and neck cancer	0.00138	0.00275	CcSEcCtD
Cevimeline—Thrombocytopenia—Vinblastine—head and neck cancer	0.00135	0.00269	CcSEcCtD
Cevimeline—Epistaxis—Fluorouracil—head and neck cancer	0.00134	0.00267	CcSEcCtD
Cevimeline—Convulsion—Hydroxyurea—head and neck cancer	0.00134	0.00266	CcSEcCtD
Cevimeline—Hyponatraemia—Docetaxel—head and neck cancer	0.00134	0.00266	CcSEcCtD
Cevimeline—Sinusitis—Fluorouracil—head and neck cancer	0.00133	0.00266	CcSEcCtD
Cevimeline—Pain in extremity—Docetaxel—head and neck cancer	0.00133	0.00265	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00133	0.00265	CcSEcCtD
Cevimeline—Agranulocytosis—Fluorouracil—head and neck cancer	0.00133	0.00264	CcSEcCtD
Cevimeline—Anorexia—Vinblastine—head and neck cancer	0.00132	0.00262	CcSEcCtD
Cevimeline—Migraine—Docetaxel—head and neck cancer	0.00131	0.00261	CcSEcCtD
Cevimeline—Discomfort—Hydroxyurea—head and neck cancer	0.0013	0.00258	CcSEcCtD
Cevimeline—Haemoglobin—Fluorouracil—head and neck cancer	0.00128	0.00255	CcSEcCtD
Cevimeline—Rhinitis—Fluorouracil—head and neck cancer	0.00128	0.00255	CcSEcCtD
Cevimeline—Haemorrhage—Fluorouracil—head and neck cancer	0.00128	0.00254	CcSEcCtD
Cevimeline—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00127	0.00253	CcSEcCtD
Cevimeline—Pharyngitis—Fluorouracil—head and neck cancer	0.00127	0.00252	CcSEcCtD
Cevimeline—Oedema—Hydroxyurea—head and neck cancer	0.00126	0.00251	CcSEcCtD
Cevimeline—Infection—Hydroxyurea—head and neck cancer	0.00125	0.00249	CcSEcCtD
Cevimeline—Paraesthesia—Vinblastine—head and neck cancer	0.00124	0.00247	CcSEcCtD
Cevimeline—Dehydration—Docetaxel—head and neck cancer	0.00124	0.00247	CcSEcCtD
Cevimeline—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00124	0.00246	CcSEcCtD
Cevimeline—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00123	0.00246	CcSEcCtD
Cevimeline—Skin disorder—Hydroxyurea—head and neck cancer	0.00122	0.00244	CcSEcCtD
Cevimeline—Dry skin—Docetaxel—head and neck cancer	0.00122	0.00243	CcSEcCtD
Cevimeline—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00122	0.00242	CcSEcCtD
Cevimeline—Anorexia—Hydroxyurea—head and neck cancer	0.0012	0.00239	CcSEcCtD
Cevimeline—Decreased appetite—Vinblastine—head and neck cancer	0.0012	0.00239	CcSEcCtD
Cevimeline—Pain—Vinblastine—head and neck cancer	0.00118	0.00235	CcSEcCtD
Cevimeline—Constipation—Vinblastine—head and neck cancer	0.00118	0.00235	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00117	0.00234	CcSEcCtD
Cevimeline—Dysphagia—Docetaxel—head and neck cancer	0.00115	0.00229	CcSEcCtD
Cevimeline—Arrhythmia—Fluorouracil—head and neck cancer	0.00114	0.00227	CcSEcCtD
Cevimeline—Feeling abnormal—Vinblastine—head and neck cancer	0.00114	0.00227	CcSEcCtD
Cevimeline—Bronchospasm—Docetaxel—head and neck cancer	0.00113	0.00225	CcSEcCtD
Cevimeline—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00113	0.00225	CcSEcCtD
Cevimeline—Alopecia—Fluorouracil—head and neck cancer	0.00113	0.00225	CcSEcCtD
Cevimeline—Dyspnoea—Hydroxyurea—head and neck cancer	0.00112	0.00224	CcSEcCtD
Cevimeline—Angina pectoris—Docetaxel—head and neck cancer	0.00112	0.00223	CcSEcCtD
Cevimeline—Somnolence—Hydroxyurea—head and neck cancer	0.00112	0.00223	CcSEcCtD
Cevimeline—Dyspepsia—Hydroxyurea—head and neck cancer	0.00111	0.00221	CcSEcCtD
Cevimeline—Decreased appetite—Hydroxyurea—head and neck cancer	0.0011	0.00218	CcSEcCtD
Cevimeline—Abdominal pain—Vinblastine—head and neck cancer	0.00109	0.00217	CcSEcCtD
Cevimeline—Fatigue—Hydroxyurea—head and neck cancer	0.00109	0.00216	CcSEcCtD
Cevimeline—Pain—Hydroxyurea—head and neck cancer	0.00108	0.00214	CcSEcCtD
Cevimeline—Constipation—Hydroxyurea—head and neck cancer	0.00108	0.00214	CcSEcCtD
Cevimeline—Weight increased—Docetaxel—head and neck cancer	0.00105	0.00209	CcSEcCtD
Cevimeline—Weight decreased—Docetaxel—head and neck cancer	0.00104	0.00207	CcSEcCtD
Cevimeline—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00104	0.00207	CcSEcCtD
Cevimeline—Pneumonia—Docetaxel—head and neck cancer	0.00103	0.00205	CcSEcCtD
Cevimeline—Anaemia—Fluorouracil—head and neck cancer	0.00103	0.00204	CcSEcCtD
Cevimeline—Hypersensitivity—Vinblastine—head and neck cancer	0.00102	0.00203	CcSEcCtD
Cevimeline—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00101	0.00201	CcSEcCtD
Cevimeline—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00101	0.002	CcSEcCtD
Cevimeline—Myocardial infarction—Docetaxel—head and neck cancer	0.00101	0.002	CcSEcCtD
Cevimeline—Stomatitis—Docetaxel—head and neck cancer	0.001	0.00199	CcSEcCtD
Cevimeline—Conjunctivitis—Docetaxel—head and neck cancer	0.000997	0.00199	CcSEcCtD
Cevimeline—Body temperature increased—Hydroxyurea—head and neck cancer	0.000996	0.00198	CcSEcCtD
Cevimeline—Leukopenia—Fluorouracil—head and neck cancer	0.000995	0.00198	CcSEcCtD
Cevimeline—Asthenia—Vinblastine—head and neck cancer	0.000991	0.00197	CcSEcCtD
Cevimeline—Epistaxis—Docetaxel—head and neck cancer	0.000968	0.00193	CcSEcCtD
Cevimeline—Convulsion—Fluorouracil—head and neck cancer	0.000963	0.00192	CcSEcCtD
Cevimeline—Agranulocytosis—Docetaxel—head and neck cancer	0.000958	0.00191	CcSEcCtD
Cevimeline—Chest pain—Fluorouracil—head and neck cancer	0.000946	0.00188	CcSEcCtD
Cevimeline—Myalgia—Fluorouracil—head and neck cancer	0.000946	0.00188	CcSEcCtD
Cevimeline—Diarrhoea—Vinblastine—head and neck cancer	0.000945	0.00188	CcSEcCtD
Cevimeline—Discomfort—Fluorouracil—head and neck cancer	0.000935	0.00186	CcSEcCtD
Cevimeline—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000928	0.00185	CcSEcCtD
Cevimeline—Haemoglobin—Docetaxel—head and neck cancer	0.000926	0.00184	CcSEcCtD
Cevimeline—Rhinitis—Docetaxel—head and neck cancer	0.000924	0.00184	CcSEcCtD
Cevimeline—Haemorrhage—Docetaxel—head and neck cancer	0.000921	0.00183	CcSEcCtD
Cevimeline—Hypoaesthesia—Docetaxel—head and neck cancer	0.000917	0.00182	CcSEcCtD
Cevimeline—Confusional state—Fluorouracil—head and neck cancer	0.000914	0.00182	CcSEcCtD
Cevimeline—Pharyngitis—Docetaxel—head and neck cancer	0.000914	0.00182	CcSEcCtD
Cevimeline—Dizziness—Vinblastine—head and neck cancer	0.000913	0.00182	CcSEcCtD
Cevimeline—Oedema peripheral—Docetaxel—head and neck cancer	0.000907	0.00181	CcSEcCtD
Cevimeline—Oedema—Fluorouracil—head and neck cancer	0.000907	0.00181	CcSEcCtD
Cevimeline—Asthenia—Hydroxyurea—head and neck cancer	0.000904	0.0018	CcSEcCtD
Cevimeline—Urethral disorder—Docetaxel—head and neck cancer	0.000903	0.0018	CcSEcCtD
Cevimeline—Infection—Fluorouracil—head and neck cancer	0.000901	0.00179	CcSEcCtD
Cevimeline—Nervous system disorder—Fluorouracil—head and neck cancer	0.000889	0.00177	CcSEcCtD
Cevimeline—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000888	0.00177	CcSEcCtD
Cevimeline—Visual impairment—Docetaxel—head and neck cancer	0.000888	0.00177	CcSEcCtD
Cevimeline—Tachycardia—Fluorouracil—head and neck cancer	0.000885	0.00176	CcSEcCtD
Cevimeline—Vomiting—Vinblastine—head and neck cancer	0.000878	0.00175	CcSEcCtD
Cevimeline—Headache—Vinblastine—head and neck cancer	0.000865	0.00172	CcSEcCtD
Cevimeline—Anorexia—Fluorouracil—head and neck cancer	0.000864	0.00172	CcSEcCtD
Cevimeline—Diarrhoea—Hydroxyurea—head and neck cancer	0.000862	0.00172	CcSEcCtD
Cevimeline—Eye disorder—Docetaxel—head and neck cancer	0.000861	0.00171	CcSEcCtD
Cevimeline—Cardiac disorder—Docetaxel—head and neck cancer	0.000855	0.0017	CcSEcCtD
Cevimeline—Flushing—Docetaxel—head and neck cancer	0.000855	0.0017	CcSEcCtD
Cevimeline—Hypotension—Fluorouracil—head and neck cancer	0.000847	0.00169	CcSEcCtD
Cevimeline—Angiopathy—Docetaxel—head and neck cancer	0.000836	0.00166	CcSEcCtD
Cevimeline—Dizziness—Hydroxyurea—head and neck cancer	0.000833	0.00166	CcSEcCtD
Cevimeline—Chills—Docetaxel—head and neck cancer	0.000827	0.00165	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000826	0.00164	CcSEcCtD
Cevimeline—Arrhythmia—Docetaxel—head and neck cancer	0.000823	0.00164	CcSEcCtD
Cevimeline—Nausea—Vinblastine—head and neck cancer	0.000821	0.00163	CcSEcCtD
Cevimeline—Insomnia—Fluorouracil—head and neck cancer	0.00082	0.00163	CcSEcCtD
Cevimeline—Paraesthesia—Fluorouracil—head and neck cancer	0.000814	0.00162	CcSEcCtD
Cevimeline—Alopecia—Docetaxel—head and neck cancer	0.000814	0.00162	CcSEcCtD
Cevimeline—Dyspnoea—Fluorouracil—head and neck cancer	0.000808	0.00161	CcSEcCtD
Cevimeline—Somnolence—Fluorouracil—head and neck cancer	0.000806	0.0016	CcSEcCtD
Cevimeline—Malnutrition—Docetaxel—head and neck cancer	0.000802	0.0016	CcSEcCtD
Cevimeline—Vomiting—Hydroxyurea—head and neck cancer	0.000801	0.00159	CcSEcCtD
Cevimeline—Dyspepsia—Fluorouracil—head and neck cancer	0.000798	0.00159	CcSEcCtD
Cevimeline—Rash—Hydroxyurea—head and neck cancer	0.000794	0.00158	CcSEcCtD
Cevimeline—Dermatitis—Hydroxyurea—head and neck cancer	0.000794	0.00158	CcSEcCtD
Cevimeline—Headache—Hydroxyurea—head and neck cancer	0.000789	0.00157	CcSEcCtD
Cevimeline—Decreased appetite—Fluorouracil—head and neck cancer	0.000788	0.00157	CcSEcCtD
Cevimeline—Dysgeusia—Docetaxel—head and neck cancer	0.000785	0.00156	CcSEcCtD
Cevimeline—Back pain—Docetaxel—head and neck cancer	0.000776	0.00154	CcSEcCtD
Cevimeline—Pain—Fluorouracil—head and neck cancer	0.000775	0.00154	CcSEcCtD
Cevimeline—Muscle spasms—Docetaxel—head and neck cancer	0.000771	0.00153	CcSEcCtD
Cevimeline—Nausea—Hydroxyurea—head and neck cancer	0.000748	0.00149	CcSEcCtD
Cevimeline—Feeling abnormal—Fluorouracil—head and neck cancer	0.000747	0.00149	CcSEcCtD
Cevimeline—Anaemia—Docetaxel—head and neck cancer	0.000741	0.00148	CcSEcCtD
Cevimeline—Urticaria—Fluorouracil—head and neck cancer	0.00072	0.00143	CcSEcCtD
Cevimeline—Syncope—Docetaxel—head and neck cancer	0.000719	0.00143	CcSEcCtD
Cevimeline—Leukopenia—Docetaxel—head and neck cancer	0.000718	0.00143	CcSEcCtD
Cevimeline—Body temperature increased—Fluorouracil—head and neck cancer	0.000717	0.00143	CcSEcCtD
Cevimeline—Palpitations—Docetaxel—head and neck cancer	0.000709	0.00141	CcSEcCtD
Cevimeline—Loss of consciousness—Docetaxel—head and neck cancer	0.000705	0.0014	CcSEcCtD
Cevimeline—Cough—Docetaxel—head and neck cancer	0.0007	0.00139	CcSEcCtD
Cevimeline—Convulsion—Docetaxel—head and neck cancer	0.000695	0.00138	CcSEcCtD
Cevimeline—Hypertension—Docetaxel—head and neck cancer	0.000692	0.00138	CcSEcCtD
Cevimeline—Arthralgia—Docetaxel—head and neck cancer	0.000683	0.00136	CcSEcCtD
Cevimeline—Chest pain—Docetaxel—head and neck cancer	0.000683	0.00136	CcSEcCtD
Cevimeline—Myalgia—Docetaxel—head and neck cancer	0.000683	0.00136	CcSEcCtD
Cevimeline—Hypersensitivity—Fluorouracil—head and neck cancer	0.000668	0.00133	CcSEcCtD
Cevimeline—Confusional state—Docetaxel—head and neck cancer	0.00066	0.00131	CcSEcCtD
Cevimeline—Oedema—Docetaxel—head and neck cancer	0.000654	0.0013	CcSEcCtD
Cevimeline—Infection—Docetaxel—head and neck cancer	0.00065	0.00129	CcSEcCtD
Cevimeline—Shock—Docetaxel—head and neck cancer	0.000644	0.00128	CcSEcCtD
Cevimeline—Nervous system disorder—Docetaxel—head and neck cancer	0.000642	0.00128	CcSEcCtD
Cevimeline—Pruritus—Fluorouracil—head and neck cancer	0.000642	0.00128	CcSEcCtD
Cevimeline—Thrombocytopenia—Docetaxel—head and neck cancer	0.000641	0.00128	CcSEcCtD
Cevimeline—Tachycardia—Docetaxel—head and neck cancer	0.000639	0.00127	CcSEcCtD
Cevimeline—Skin disorder—Docetaxel—head and neck cancer	0.000636	0.00127	CcSEcCtD
Cevimeline—Anorexia—Docetaxel—head and neck cancer	0.000624	0.00124	CcSEcCtD
Cevimeline—Diarrhoea—Fluorouracil—head and neck cancer	0.00062	0.00124	CcSEcCtD
Cevimeline—Hypotension—Docetaxel—head and neck cancer	0.000612	0.00122	CcSEcCtD
Cevimeline—Dizziness—Fluorouracil—head and neck cancer	0.0006	0.00119	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000596	0.00119	CcSEcCtD
Cevimeline—Insomnia—Docetaxel—head and neck cancer	0.000592	0.00118	CcSEcCtD
Cevimeline—Paraesthesia—Docetaxel—head and neck cancer	0.000588	0.00117	CcSEcCtD
Cevimeline—Dyspnoea—Docetaxel—head and neck cancer	0.000583	0.00116	CcSEcCtD
Cevimeline—Somnolence—Docetaxel—head and neck cancer	0.000582	0.00116	CcSEcCtD
Cevimeline—Vomiting—Fluorouracil—head and neck cancer	0.000577	0.00115	CcSEcCtD
Cevimeline—Dyspepsia—Docetaxel—head and neck cancer	0.000576	0.00115	CcSEcCtD
Cevimeline—Rash—Fluorouracil—head and neck cancer	0.000572	0.00114	CcSEcCtD
Cevimeline—Dermatitis—Fluorouracil—head and neck cancer	0.000571	0.00114	CcSEcCtD
Cevimeline—Decreased appetite—Docetaxel—head and neck cancer	0.000569	0.00113	CcSEcCtD
Cevimeline—Headache—Fluorouracil—head and neck cancer	0.000568	0.00113	CcSEcCtD
Cevimeline—Fatigue—Docetaxel—head and neck cancer	0.000564	0.00112	CcSEcCtD
Cevimeline—Constipation—Docetaxel—head and neck cancer	0.00056	0.00111	CcSEcCtD
Cevimeline—Pain—Docetaxel—head and neck cancer	0.00056	0.00111	CcSEcCtD
Cevimeline—Feeling abnormal—Docetaxel—head and neck cancer	0.000539	0.00107	CcSEcCtD
Cevimeline—Nausea—Fluorouracil—head and neck cancer	0.000539	0.00107	CcSEcCtD
Cevimeline—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000535	0.00107	CcSEcCtD
Cevimeline—Abdominal pain—Docetaxel—head and neck cancer	0.000517	0.00103	CcSEcCtD
Cevimeline—Body temperature increased—Docetaxel—head and neck cancer	0.000517	0.00103	CcSEcCtD
Cevimeline—Hypersensitivity—Docetaxel—head and neck cancer	0.000482	0.00096	CcSEcCtD
Cevimeline—Asthenia—Docetaxel—head and neck cancer	0.00047	0.000935	CcSEcCtD
Cevimeline—Pruritus—Docetaxel—head and neck cancer	0.000463	0.000922	CcSEcCtD
Cevimeline—Diarrhoea—Docetaxel—head and neck cancer	0.000448	0.000891	CcSEcCtD
Cevimeline—Dizziness—Docetaxel—head and neck cancer	0.000433	0.000862	CcSEcCtD
Cevimeline—Vomiting—Docetaxel—head and neck cancer	0.000416	0.000828	CcSEcCtD
Cevimeline—Rash—Docetaxel—head and neck cancer	0.000413	0.000821	CcSEcCtD
Cevimeline—Dermatitis—Docetaxel—head and neck cancer	0.000412	0.000821	CcSEcCtD
Cevimeline—Headache—Docetaxel—head and neck cancer	0.00041	0.000816	CcSEcCtD
Cevimeline—Nausea—Docetaxel—head and neck cancer	0.000389	0.000774	CcSEcCtD
